资本发行是一种资本发行.

Gordon B Drummond

Lancet (London, England)

|September 27, 2003

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Small changes in hand height alter absorbance, but not pulsation, in the finger pulse plethysmograph.

Physiological measurement·2026

Same author

Classifying signals from a wearable accelerometer device to measure respiratory rate.

ERJ open research·2021

Same author

Current clinical methods of measurement of respiratory rate give imprecise values.

ERJ open research·2020

Same author

Letter to the Editor: Response to Luke Fletcher and Philip Peyton regarding "Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients".

Intensive care medicine experimental·2020

Same author

Correction to: Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients.

Intensive care medicine experimental·2020

Same author

Neurologic Examination for Anesthesiologists: Comment.

Anesthesiology·2019

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

资本发行是一种资本发行.

相关概念视频

Small changes in hand height alter absorbance, but not pulsation, in the finger pulse plethysmograph.

Classifying signals from a wearable accelerometer device to measure respiratory rate.

Current clinical methods of measurement of respiratory rate give imprecise values.

Letter to the Editor: Response to Luke Fletcher and Philip Peyton regarding "Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients".

Correction to: Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients.

Neurologic Examination for Anesthesiologists: Comment.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

资本发行是一种资本发行.

相关概念视频

Small changes in hand height alter absorbance, but not pulsation, in the finger pulse plethysmograph.

Classifying signals from a wearable accelerometer device to measure respiratory rate.

Current clinical methods of measurement of respiratory rate give imprecise values.

Letter to the Editor: Response to Luke Fletcher and Philip Peyton regarding "Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients".

Correction to: Predictive validity of a novel non-invasive estimation of effective shunt fraction in critically ill patients.

Neurologic Examination for Anesthesiologists: Comment.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.